Some of the factors found in the pro-inflammatory cytokines panel are well known biomarkers of circadian and sleep disruption (TNF-a and IL-6, see above), whereas the others have not previously been coupled to sleep disruption in cancer patients (e.g., GM-CSF). The gene discussed is IL6; the disease is cancer.